Intuitive Surgical, Inc., together with its subsidiaries, designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories.
No risks detected for ISRG from our risk checks.
Flawless balance sheet with solid track record.
Share Price & News
How has Intuitive Surgical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ISRG has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: ISRG underperformed the US Medical Equipment industry which returned 22.1% over the past year.
Return vs Market: ISRG underperformed the US Market which returned 20.1% over the past year.
Price Volatility Vs. Market
How volatile is Intuitive Surgical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall StNeed To Know: Intuitive Surgical, Inc. (NASDAQ:ISRG) Insiders Have Been Selling Shares
2 weeks ago | Simply Wall StShould You Rely On Intuitive Surgical's (NASDAQ:ISRG) Earnings Growth?
3 weeks ago | Simply Wall StWhy Intuitive Surgical, Inc.'s (NASDAQ:ISRG) High P/E Ratio Isn't Necessarily A Bad Thing
Is Intuitive Surgical undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ISRG ($603.36) is trading above our estimate of fair value ($484.62)
Significantly Below Fair Value: ISRG is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ISRG is poor value based on its PE Ratio (50.5x) compared to the Medical Equipment industry average (47.1x).
PE vs Market: ISRG is poor value based on its PE Ratio (50.5x) compared to the US market (18.4x).
Price to Earnings Growth Ratio
PEG Ratio: ISRG is poor value based on its PEG Ratio (5.1x)
Price to Book Ratio
PB vs Industry: ISRG is overvalued based on its PB Ratio (8.5x) compared to the US Medical Equipment industry average (4x).
How is Intuitive Surgical forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ISRG's forecast earnings growth (10% per year) is above the savings rate (1.7%).
Earnings vs Market: ISRG's earnings (10% per year) are forecast to grow slower than the US market (14.5% per year).
High Growth Earnings: ISRG's earnings are forecast to grow, but not significantly.
Revenue vs Market: ISRG's revenue (11.7% per year) is forecast to grow faster than the US market (7.6% per year).
High Growth Revenue: ISRG's revenue (11.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ISRG's Return on Equity is forecast to be low in 3 years time (17.1%).
How has Intuitive Surgical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ISRG has high quality earnings.
Growing Profit Margin: ISRG's current net profit margins (30.8%) are higher than last year (30.3%).
Past Earnings Growth Analysis
Earnings Trend: ISRG's earnings have grown significantly by 20.4% per year over the past 5 years.
Accelerating Growth: ISRG's earnings growth over the past year (22.3%) exceeds its 5-year average (20.4% per year).
Earnings vs Industry: ISRG earnings growth over the past year (22.3%) exceeded the Medical Equipment industry 7.1%.
Return on Equity
High ROE: ISRG's Return on Equity (16.7%) is considered low.
Return on Assets
Return on Capital Employed
How is Intuitive Surgical's financial position?
Financial Position Analysis
Short Term Liabilities: ISRG's short term assets ($4.7B) exceed its short term liabilities ($1.0B).
Long Term Liabilities: ISRG's short term assets ($4.7B) exceed its long term liabilities ($418.3M).
Debt to Equity History and Analysis
Debt Level: ISRG is debt free.
Reducing Debt: ISRG has not had any debt for past 5 years.
Debt Coverage: ISRG has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ISRG has no debt, therefore coverage of interest payments is not a concern.
Inventory Level: ISRG has a low level of unsold assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if ISRG's debt is covered by short term assets.
What is Intuitive Surgical's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate ISRG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate ISRG's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ISRG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ISRG's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ISRG's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Gary Guthart (53yo)
Dr. Gary S. Guthart, Ph.D., has been Chief Executive Officer of Intuitive Surgical, Inc. since January 01, 2010 and also had been its President since July 12, 2007 until 2019. Dr. Guthart served as the Chi ...
CEO Compensation Analysis
Compensation vs Market: Gary's total compensation ($USD6.42M) is below average for companies of similar size in the US market ($USD10.81M).
Compensation vs Earnings: Gary's compensation has increased by more than 20% in the past year.
|CEO & Director||10.1yrs||US$6.42m||0.33% $230.1m|
|Executive VP & CFO||0yrs||US$3.33m||0.011% $7.9m|
|Consultant & Advisor||0.08yrs||US$4.58m||0.0036% $2.5m|
|Executive VP & Chief Business Officer||7.1yrs||US$4.54m||0.0087% $6.1m|
|Executive VP & Chief Medical Officer||14.2yrs||US$4.15m||0.0026% $1.8m|
|VP, Corporate Controller & Principal Accounting Officer||6.3yrs||no data||0.00018% $126.0k|
|Senior Director of IR||0yrs||no data||no data|
|Senior VP||1.6yrs||no data||0.0024% $1.7m|
|Senior Vice President of Corporate Development & Strategy||1.1yrs||no data||no data|
|Senior Vice President of Human Resources||1.1yrs||no data||no data|
Experienced Management: ISRG's management team is considered experienced (4 years average tenure).
|CEO & Director||10.1yrs||US$6.42m||0.33% $230.1m|
|Independent Director||9.8yrs||US$364.57k||0.0079% $5.6m|
|Independent Chairman||16.8yrs||US$445.97k||0.52% $366.9m|
|Independent lead Director||1.8yrs||US$399.27k||0.0063% $4.4m|
|Independent Director||20yrs||US$363.57k||0.0065% $4.6m|
|Independent Director||2.8yrs||US$350.57k||0.00073% $510.9k|
|Independent Director||4.1yrs||US$354.57k||0.00029% $202.9k|
|Director||0.5yrs||no data||no data|
|Independent Director||12.3yrs||US$367.57k||0.0037% $2.6m|
Experienced Board: ISRG's board of directors are considered experienced (7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ISRG insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Intuitive Surgical, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Intuitive Surgical, Inc.
- Ticker: ISRG
- Exchange: NasdaqGS
- Founded: 1995
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$69.980b
- Shares outstanding: 115.98m
- Website: https://www.intuitive.com
Number of Employees
- Intuitive Surgical, Inc.
- 1020 Kifer Road
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ISRG||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Jun 2000|
|IUI1||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Jun 2000|
|0R29||LSE (London Stock Exchange)||Yes||Common Stock||GB||USD||Jun 2000|
|ISRG||WBAG (Wiener Boerse AG)||Yes||Common Stock||AT||EUR||Jun 2000|
|ISRG *||BMV (Bolsa Mexicana de Valores)||Yes||Common Stock||MX||MXN||Jun 2000|
|IUI1||ETLX (Eurotlx)||Yes||Common Stock||IT||EUR||Jun 2000|
|I1SR34||BOVESPA (Bolsa de Valores de Sao Paulo)||BDR EACH 10 REPR 1 COM||BR||BRL||Jan 2020|
Intuitive Surgical, Inc., together with its subsidiaries, designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company’s da Vinci Surgical System include surgeon’s consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; and EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. It markets its products directly and through distributors in the United States, Europe, Asia, and internationally. The company was founded in 1995 and is headquartered in Sunnyvale, California.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/16 23:38|
|End of Day Share Price||2020/02/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.